Connor, K., M. Harris , M. Edwards, A. Chu, G. Clark, and B. Finley. 2004. Estimating the total TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Dioxin 2004 . September 6-10, 2004. Berlin, Germany.
Publication: Abstracts and Presentations
Gay EA, Urban JD, Nichols DE, Oxford GS, and Mailman RB. 2004. Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states. Mol Pharmacol . 66 (1): 97 – 105.
Publication: Manuscripts
Haws, L . Roundtable: Is it Time to Reevaluate the Toxic Equivalency Factors for PCDDs, PCDFs, and Dioxin-Like PCBs? The Use of Toxicity Equivalence Factors (TEFs) for PCDDs, PCDFs, and Dioxin-Like PCBs in Risk Assessment: Improving the Process. Dioxin 2004 . September 6-10, 2004. Berlin, Germany.
Publication: Abstracts and Presentations
Proctor DM , Panko JP, Liebig EW, Paustenbach, DJ. 2004. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940–1972. Occup Environ Hyg . 1:752–767.
Publication: Manuscripts
/ Topics: Hexavalent Chromium
Haws, L. , M. Harris , S. Su, L. Birnbaum, M. DeVito, W. Farland, N. Walker, K. Connor, A.Santamaria, and B. Finley. Development of a refined database of relative potency estimates to facilitate better characterization of variability and uncertainty in the current mammalian TEFs for PCDDs, PDCFs, and dioxin-like PCBs. Dioxin 2004 . September 6-10, 2004. Berlin, Germany.
Publication: Abstracts and Presentations
Schecter, A, Papke O, Tung KC, Staskal DF , and Birnbaum L. 2004. Polybrominated diphenyl ether contamination of United States food. Environ Sci Technol . 38(20): 5306-11.
Publication: Manuscripts
/ Topics: Hexavalent Chromium
Thompson CM , Wojno H, Greiner E, May EL, Rice KC, and Selley DE. 2004. Activation of G-proteins by Morphine and Codeine Congeners: Insights to the Relevance of O- and N-Demethylated Metabolites at μ- and δ-Opioid Receptors. Journal of Pharmacology and Experimental Therapeutics . 308(2), 547–554.
Publication: Manuscripts
Haws, L. , M. Harris , S. Su, N. Walker, L. Birnbaum, M. DeVito, W. Farland, K. Connor, A. Santamaria, and B. Finley. A preliminary approach to characterizing variability and uncertainty in the mammalian PCDD/F and PCB TEFs. Dioxin 2004 . September 6-10, 2004. Berlin, Germany.
Publication: Abstracts and Presentations
Perry, C.S . and Morton, E. Lessons learned from creating integrated Excel models to calculate human health screening values. Society for Risk Analysis’ Annual Meeting. December 5-8, 2004. Palm Springs, CA.